<p>Charani Ranasinghe of The Australian National University will test a new vaccine technology that modulates a host cytokine response to HIV vaccines. If successful, this "cytokine trap" technology may also enhance T-cell mediated immunity to other vaccine antigens, such as Tuberculosis.</p>


Charani Ranasinghe of The Australian National University will test a new vaccine technology that modulates a host cytokine response to HIV vaccines. If successful, this "cytokine trap" technology may also enhance T-cell mediated immunity to other vaccine antigens, such as Tuberculosis.